Testing effectiveness (Phase 2)Study completedNCT00003796What this trial is testingIrofulven in Treating Patients With Metastatic Breast CancerWho this might be right forBreast Cancer National Cancer Institute (NCI) 32
Not applicableEnded earlyNCT02149173What this trial is testingF-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted TherapyWho this might be right forEstrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7 University of Washington 29
Testing effectiveness (Phase 2)Study completedNCT00662129What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 50
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Testing effectiveness (Phase 2)Study completedNCT03633331What this trial is testingPalbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerHER2/Neu NegativeStage IV Breast Cancer AJCC v6 and v7 Alliance for Clinical Trials in Oncology 93
Early research (Phase 1)Study completedNCT03207529What this trial is testingAlpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast CancerWho this might be right forAdvanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+15 more M.D. Anderson Cancer Center 18
Early research (Phase 1)Study completedNCT01009437What this trial is testingRitonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast CancerWho this might be right forBreast Cancer Masonic Cancer Center, University of Minnesota 28
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00002509What this trial is testingHigh-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast CancerWho this might be right forBreast Cancer Temple University
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT01327781What this trial is testingZ-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast CancerWho this might be right forHER2/Neu PositiveRecurrent Breast CarcinomaStage IIIC Breast Cancer AJCC v7+1 more National Cancer Institute (NCI) 62
Large-scale testing (Phase 3)Ended earlyNCT00272987What this trial is testingErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and LapatinibWho this might be right forNeoplasms, Breast Novartis Pharmaceuticals 63
Testing effectiveness (Phase 2)Looking for participantsNCT04090567What this trial is testingOlaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerWho this might be right forAdvanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00617539What this trial is testingIrinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain MetastasesWho this might be right forBreast CancerMetastatic Cancer University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT00368875What this trial is testingPhase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast CancerWho this might be right forMale Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer+1 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00006007What this trial is testingLY231514 Plus Gemcitabine in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 59
Not applicableUnknownNCT00938756What this trial is testingStudy of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal SyndromeWho this might be right forBrain and Central Nervous System TumorsBreast CancerMetastatic Cancer Centre Oscar Lambret 80
Testing effectiveness (Phase 2)Study completedNCT00274456What this trial is testingPhase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast CancerWho this might be right forMetastatic Breast Cancer Celgene 302